Adragos Pharma is pleased to announce its participation in Interphex 2025, taking place in Tokyo, Japan, from July 9-11. As a global Contract Development and Manufacturing Organization (CDMO), we look forward to connecting with industry leaders, partners, and innovators to discuss the future of pharmaceutical development, manufacturing, and commercialization.
Our Commitment to Pharmaceutical Innovation
Interphex is a premier event for showcasing innovation, technology, and collaboration in the pharmaceutical and bioprocessing sectors. Adragos Pharma will take part to this event, where a team of local experts offer deep regulatory knowledge, technical expertise, and experience tailored to both Japanese and non-Japanese pharmaceutical companies.
We are committed to:
✔ Providing seamless CDMO solutions for pharmaceutical development, manufacturing, and packaging that meet Japanese quality and regulatory standards
✔ Guiding non-Japanese companies through every step of Japanese market entry—from registration to commercialization
✔ Supporting Japanese companies with innovative strategies for operational excellence and supply chain optimization
✔ Ensuring a smooth, compliant, and efficient path to success in Japan’s dynamic pharmaceutical landscape
Visit us at INTERPHEX to discover how our Kawagoe facility and expert team can help you navigate and thrive in the Japanese market.
Meet Our Team at Interphex 2025
We are delighted to share that Henny Zijlstra (Chief Commercial Officer), Masanori Kurogome (Site Head), Hideyuki Tanaka (Head of Commercial US & APAC), and Munetaka Hirosaki (Customer Relationship Manager) will be available for discussions during the event.
Henny Zijlstra, Chief Commercial Officer (CCO)
Henny Zijlstra brings extensive expertise in pharmaceutical manufacturing and business development. She is dedicated to fostering strong client partnerships and driving innovative, customer-centric solutions in the CDMO space.
Masanori Kurogome, Site Head (Kawagoe)
Masanori holds a pharmacy degree with a focus on analytical chemistry. His experience in production broadened his expertise. In 2018, he started programming to expand his skill set. Kurogome is committed to making Adragos Kawagoe an irreplaceable site.
Hideyuki Tanaka, Head of Commercial US & APAC
Hide serves as Adragos’ Head Commercial US & APAC and brings over two decades of experience within the pharmaceutical and CDMO industry. He has an extensive global background spanning the United States, Europe, and Japan.
Munetaka Hirosaki, Customer Relationship Manager (Kawagoe)
Munetaka has extensive experience in supply chain management, production, and operational excellence. Previously at Sanofi, he specializes in business development, order management, and strategic customer relations in the pharmaceutical industry.
Connect with Us in Tokyo
Our team will be attending Interphex 2025, and we welcome the opportunity to engage in discussions on potential collaborations, market insights, and strategic partnerships. If you are attending, we invite you to connect with us during the event.
📅 July 9-11, 2025
📍 Tokyo, Japan
We look forward to productive discussions and new opportunities to drive innovation in pharmaceutical manufacturing and development.
